Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy
Andrew Advani, Kathryn J Wiggins, Alison J Cox, Yuan Zhang, Richard E Gilbert, Darren J Kelly
Nephrology | WILEY | Published : 2011
The authors thank Mariana Pacheco, Sylwia Glowacka, Jemma Court and Suzanne Advani for their excellent technical assistance. Dr Andrew Advani is a Canadian Diabetes Association Clinician Scientist. Dr Richard E. Gilbert is a Canada Research Chair in Diabetes Complications. Dr Darren Kelly is an NHMRC Senior Fellow. This research was undertaken, in part, thanks to funding from the Canadian Diabetes Association, the CIHR and the Canada Research Chairs programme.A.A., R.E.G. and D.J.K. have received research funding and/or honoraria from Novartis Pharmaceuticals, the manufacturer of PKI 166, the compound used in this study.